EL7.AI
Mergers & AcquisitionsMediumUpdated•Originally published 8 October 2026•Updated 8 October 2026•
1 min read

UK CMA Accepts Brink's Remedy for NCR Atleos Acquisition

Key Facts

1The UK Competition and Markets Authority (CMA) has accepted in principle Brink's proposed remedy to divest assets to avoid a Phase 2 investigation.
2The proposed remedy involves the divestiture of NoteMachine and TestLink UK units to facilitate the acquisition's progress.
3Brink's expects the acquisition of NCR Atleos to close in early Q1 2027.

The UK Competition and Markets Authority (CMA) has accepted in principle a remedy proposed by The Brink's Company to divest certain assets to avoid a Phase 2 investigation into its acquisition of NCR Atleos. GlobeNewswire reported that the proposal involves the sale of the NoteMachine and TestLink UK units to facilitate the transaction's progress. Brink's expects the acquisition to close in early Q1 2027.

BCO closed at $102.07 on October 7, 2026, while NATL closed at $45.47 on the same date. The regulatory acceptance in principle serves to address antitrust concerns in the UK market, marking a significant milestone in the merger process between the two financial and cash management entities.

Latest Updates · 1

  1. Notable·

    Update: The valuation for the Brink's acquisition of NCR Atleos is $4 billion. This transaction value marks a significant financial scale for the merger as the company seeks to strengthen its global position in financial and cash management solutions.